About Beacon Biosignals
Beacon Biosignals is a company based in Boston (United States) founded in 2019 by Jacob Donoghue, Brandon Westover, Jarrett Revels, and Sydney Cash. Beacon Biosignals has raised $27 million across 3 funding rounds from investors including General Catalyst, Casdin Capital and Andy Beck. The company has 47 employees as of December 31, 2024. Beacon Biosignals has completed 1 acquisition, including Dreem. Beacon Biosignals offers products and services including Dreem Headband and EEG Neurobiomarker Platform. Beacon Biosignals operates in a competitive market with competitors including Ceribell, BioSerenity, BrainScope, Mynd Analytics and Spark Biomedical, among others.
- Headquarter Boston, United States
- Employees 47 as on 31 Dec, 2024
- Founders Jacob Donoghue, Brandon Westover, Jarrett Revels, Sydney Cash
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Beacon Biosignals, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
General Catalyst
& 2 more
-
Employee Count
47
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Beacon Biosignals
Beacon Biosignals offers a comprehensive portfolio of products and services, including Dreem Headband and EEG Neurobiomarker Platform.
Wearable device for at-home EEG monitoring in clinical studies.
Platform for EEG data analysis in neurological research and trials.
People of Beacon Biosignals
Unlock access to complete
Funding Insights of Beacon Biosignals
Beacon Biosignals has successfully raised a total of $27M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Beacon Biosignals
Beacon Biosignals has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include General Catalyst, Casdin Capital and Andy Beck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
AB
Andy Beck |
-
|
Locked | Locked | Locked |
Investor details for Beacon Biosignals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beacon Biosignals
Beacon Biosignals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dreem.
Investment portfolio details for Beacon Biosignals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Sleep quality is monitored via Dreem's wearable EEG device.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Beacon Biosignals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Beacon Biosignals
Detailed financials for Beacon Biosignals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beacon Biosignals Comparisons
Peer comparison for Beacon Biosignals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Beacon Biosignals
Beacon Biosignals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, BioSerenity, BrainScope, Mynd Analytics and Spark Biomedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
|
| Locked | Locked | Locked |
Provider of reference data and analytic tools for clinicians and researchers in psychiatry.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for opioid withdrawal symptoms are developed.
|
Detailed competitors of Beacon Biosignals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beacon Biosignals
Complete news archive for Beacon Biosignals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beacon Biosignals
Beacon Biosignals was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Beacon Biosignals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jacob Donoghue is the current CEO of Beacon Biosignals. They have also founded this company.
Beacon Biosignals is a funded company, having raised a total of $27M across 3 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Beacon Biosignals is 47.
Beacon Biosignals was founded in 2019 and is based in Boston, United States. Operations focus on the healthcare sector, where an AI platform for EEG analysis and diagnosis is utilized by professionals. Real-time brain activity is captured to support studies of neurological and psychiatric diseases. Data from the platform is employed to quantify treatment plans and identify suitable patient populations.
Beacon Biosignals's top competitors include Ceribell, BrainScope and Spark Biomedical.
Beacon Biosignals offers Dreem Headband and EEG Neurobiomarker Platform.
Beacon Biosignals has made 1 acquisition, including Dreem.
Beacon Biosignals has 3 investors. Key investors include General Catalyst, Casdin Capital, and Andy Beck.